As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Digital Therapeutics Market: By Application: Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Respiratory Diseases, Others; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Digital Therapeutics Market Outlook

The global digital therapeutics market reached a value of about USD 3.6 billion in 2020. The market is further expected to grow at a CAGR of 23.1% in the forecast period of 2021-2026 to reach a value of nearly USD 12.6 billion by 2026.

 

Increasing Prevalence of Diabetes to Augment the Digital Therapeutics Industry Growth

Based on application, the diabetes segment is the major revenue generator due to the increasing incidence of diabetes, and this trend is projected to continue over the forecast period as well. Moreover, diabetes has the highest comparative incidence rates in North America, the Middle East, and North Africa, which pushes up the demand for digital therapeutics among diabetic patients in these regions. The digital therapeutics industry in North America is fuelled by factors, such as the entry of new start-ups, rising investments in digital therapeutics, changes in the reimbursement system for digital therapeutics, and government initiatives to promote technological breakthroughs.

 

Global Digital Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Digital Therapeutics: Industry Definition and Segmentation

Digital therapeutics, a category of digital health, is referred to as evidence-based therapeutic interventions powered by high-quality software programmes to prevent, manage, or treat a medical disorder or disease.

By application, the market is divided into:

  • Diabetes
  • Obesity
  • Cardiovascular Diseases (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Based on end use, the industry can be categorised into:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Growing Focus on Preventive Healthcare to Bolster the Growth of the Digital Therapeutics Industry

The rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics are all driving the market growth. Chronic diseases' high prevalence and the incidence rate is a serious problem for healthcare systems all over the world. Patients with chronic diseases provide a considerable barrier in terms of therapy, since psychosomatic or biopsychic variables frequently affect these patients. Many chronic diseases and conditions progress over time, and their prevalence rises as people get older. As a result, chronic diseases are expected to rise even more throughout the forecast period as the global geriatric population grows. This is expected to provide considerable growth opportunities for the digital therapeutics industry.

 

Key Industry Players in the Global Digital Therapeutics Market

The report gives a detailed analysis of the following key players in the global digital therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Omada Health, Inc.
  • WellDoc, Inc.
  • Livongo Health, Inc.
  • Mango Health, Inc.
  • Canary Health, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, End Use, Region
Breakup by Application Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Others
Breakup by End Use Patients, Providers, Payers, Employers, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Omada Health, Inc., WellDoc, Inc., Livongo Health, Inc., Mango Health, Inc., Canary Health, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Digital Therapeutics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Digital Therapeutics Historical Market (2016-2020) 
    8.3    Global Digital Therapeutics Market Forecast (2021-2026)
    8.4    Global Digital Therapeutics Market by Application
        8.4.1    Diabetes
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Obesity
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Cardiovascular Diseases (CVD)
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Central Nervous System (CNS) Disease
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Respiratory Diseases
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
        8.4.6    Smoking Cessation
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2016-2020)
            8.4.6.3    Forecast Trend (2021-2026)
        8.4.7    Others
    8.5    Global Digital Therapeutics Market by End Use
        8.5.1    Patients
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Providers
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Payers
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Employers
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Others
    8.6    Global Digital Therapeutics Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Omada Health, Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    WellDoc, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Livongo Health, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Mango Health, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Canary Health, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Digital Therapeutics Market: Key Industry Highlights, 2016 and 2026
2.    Global Digital Therapeutics Historical Market: Breakup by Application (USD Million), 2016-2020
3.    Global Digital Therapeutics Market Forecast: Breakup by Application (USD Million), 2021-2026
4.    Global Digital Therapeutics Historical Market: Breakup by End Use (USD Million), 2016-2020
5.    Global Digital Therapeutics Market Forecast: Breakup by End Use (USD Million), 2021-2026
6.    Global Digital Therapeutics Historical Market: Breakup by Region (USD Million), 2016-2020
7.    Global Digital Therapeutics Market Forecast: Breakup by Region (USD Million), 2021-2026
8.    North America Digital Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
9.    North America Digital Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
10.    Europe Digital Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
11.    Europe Digital Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Asia Pacific Digital Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Asia Pacific Digital Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Latin America Digital Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Latin America Digital Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Middle East and Africa Digital Therapeutics Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Middle East and Africa Digital Therapeutics Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Global Digital Therapeutics Market Structure

Key Questions Answered in the Report

In 2020, the global digital therapeutics market attained a value of nearly USD 3.6 billion.

The market is projected to grow at a CAGR of 23.1% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 12.6 billion by 2026.

The major drivers of the market include the rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics.

The market is expected to be positively influenced by the technological advancements going on in the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different applications of digital therapeutics are diabetes, obesity, cardiovascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, and smoking cessation, among others.

The various end uses of digital therapeutics are patients, providers, payers, and employers, among others.

The major players in the industry are Omada Health Inc., WellDoc Inc., Livongo Health Inc., Mango Health Inc., and Canary Health Inc., among others.

Analyst Review

The global digital therapeutics market attained a value of about USD 3.6 billion in 2020, driven by the rising prevalence of chronic diseases. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 23.1%. The market is projected to reach nearly USD 12.6 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By application, the market is divided into diabetes, obesity, cardiovascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, and smoking cessation, among others. Based on end use, the industry can be categorised into patients, providers, payers, and employers, among others. The major regional markets for digital therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Omada Health Inc., WellDoc Inc., Livongo Health Inc., Mango Health Inc., and Canary Health Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER